Hospital Universitario da A Coruna

At Hospital Universitario da A Coruna, the Oncology department is running clinical trials focused on cancer care, with studies aimed at improving treatment options for advanced and metastatic malignancies. The research includes testing new therapies, assessing how well they work, and exploring better ways to manage difficult-to-treat tumors.

• Advanced RET-altered malignancies and RET fusion-positive non-small cell lung cancer
• Advanced/metastatic breast cancer with a focus on hormone receptor-positive disease
• Low-grade upper tract urothelial cancer and treatment effectiveness in urinary tract tumors
• Non-small cell lung cancer studies evaluating new approaches for advanced disease

These trials are primarily designed to test innovative cancer therapies, measure disease control, and support better outcomes for patients with hard-to-treat solid tumors.

The site is also involved in research on virus diseases, especially Coronavirus Disease 2019 (COVID-19). These studies are examining new treatment strategies for people with weakened immune systems, with the goal of improving symptom control and viral response.

• COVID-19 in severely immunocompromised adults
• Evaluations of antiviral treatment approaches for better clinical and virological outcomes
• Research aimed at improving care for vulnerable patients with limited immune defenses

This work reflects a broader effort to refine treatment options for infectious disease patients, especially those at higher risk of complications.